InvestorsHub Logo
Followers 27
Posts 744
Boards Moderated 0
Alias Born 07/12/2012

Re: vinmantoo post# 268843

Friday, 07/22/2016 10:30:17 PM

Friday, July 22, 2016 10:30:17 PM

Post# of 346050
Vin, anti-PD1 Mabs are not the home run you're looking for


Too few responders. Overstimulation of Th1 cell-mediated immunity prompting autoimmune disorders and severe side effects for the minority who do respond.

25% of the initial 40% responders relapse anyway after 3 years.

Wishing that Bavi had a 30% response rate similar to anti-PD1s is missing the point.

The idea is how do you improve that response rate and minimize side effects.

Investors here have an idea.

You are bound to disagree, so I do post this for others.


Regards,

Joe
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News